Experimental Moderna Flu Shot More Effective than Approved Vaccine, Company Says

Moderna says its mRNA seasonal flu shot is 27% better than current vaccine

Moderna hailed the results, but the shot’s future under RFK Jr. is murky.

Experimental Moderna flu shot more effective than approved vaccine, company says

(The Hill) - Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent higher for adults 50 and older than a currently available shot. The shot also showed strong efficacy against each of the major influenza strains in the shot, including A/H1N1, A/H3N2 and the B/Victoria lineages.   Efficacy appeared consistently st…

Moderna’s New Flu Shot Shows Strong Results in Older Adults

Key Takeaways

Moderna's new flu shot shows strong results in older adults

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial, the company announced.

Moderna says flu shot more effective than rival GSK in late-stage study

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK in adults aged 50 years and older in a late-stage study, sending its shares up more than 2%.

Moderna to Ask for Clearance for Combination COVID-Influenza Vaccine

Moderna is going to ask regulators to approve its combination vaccine against COVID-19 and influenza, the company said on June 30. The company said a phase 3 study evaluating its influenza vaccine candidate, mRNA-1010—which utilizes the same messenger ribonucleic acid (mRNA) platform as its COVID-19 vaccine—showed positive effectiveness. In the trial, which featured 40,805 participants and compared mRNA-1010 to an existing seasonal flu vaccine i…